1. Role of MMP-2, MMP-9 and VEGF as serum biomarker in early prognosis of renal cell carcinoma
   S. Ahmad et al, 2018, African Journal of Urology CrossRef
2. Saliva proteomic analysis reveals possible biomarkers of renal cell carcinoma
   Xiao Li Zhang et al, 2020, Open Chemistry CrossRef
3. Does the Immunohistochemical Expression of CD44, MMP-2, and MMP-9 in Association with the Histopathological Subtype of Renal Cell Carcinoma Affect the Survival of Patients with Renal Cancer?
   Magdalena Chrabańska et al, 2023, Cancers CrossRef
4. Downregulation of the GnT-V gene inhibits metastasis and invasion of BGC823 gastric cancer cells
   BINBIN HUANG et al, 2013, Oncology Reports CrossRef
5. Matrix Metalloproteinases in Renal Diseases: A Critical Appraisal
   Oskar Zakiyanov et al, 2019, Kidney and Blood Pressure Research CrossRef
6. Immunohistochemical Expression of CD44, MMP-2, MMP-9, and Ki-67 as the Prognostic Markers in Non-Clear Cell Renal Cell Carcinomas—A Prospective Cohort Study
   Magdalena Chrabańska et al, 2022, Journal of Clinical Medicine CrossRef
7. Lymphatic filarial serum proteome profiling for identification and characterization of diagnostic biomarkers
   Vipin Kumar et al, 2022, PLOS ONE CrossRef
8. Evaluation of neutrophil gelatinase-associated lipocalin (NGAL), matrix metalloproteinase-9 (MMP-9) and their complex MMP-9/NGAL in sera and urine of patients with kidney tumors
   ANGELINA DI CARLO, 2013, Oncology Letters CrossRef
9. Serum and Urine Biomarkers for Human Renal Cell Carcinoma
   A. L. Pastore et al, 2015, Disease Markers CrossRef
10. Liraglutide protects high-glucose-stimulated fibroblasts by activating the CD36-JNK-AP1 pathway to downregulate P4HA1
    Tong Zhao et al, 2019, Biomedicine & Pharmacotherapy CrossRef
11. Promising Biomarkers in Renal Cell Carcinoma
    Jada Kapoor et al, 2021, Société Internationale d’Urologie Journal CrossRef
12. The urinary proteome and peptidome of renal cell carcinoma patients: a comparison of different techniques
    Francesca Raimondo et al, 2014, Expert Review of Proteomics CrossRef
13. PROGNOSTIC VALUE OF MATRIX METALLOPROTEINASE 9 IN RENAL CELL CARCINOMA
    T. M. Cherdantseva et al, 2018, Cancer Urology CrossRef
14. Molecular Biomarkers and Treatments for Renal Cell Carcinoma
    Juan Chipollini et al, 2016, Biomarkers in Kidney Disease CrossRef
15. Cellular uptake of proMMP-2:TIMP-2 complexes by the endocytic receptor megalin/LRP-2
    Manuel Johanns et al, 2017, Scientific Reports CrossRef
16. Caspase‑10, matrix metalloproteinase‑9 and total laminin are correlated with the tumor malignancy of clear cell renal cell carcinoma
    Hua Qian et al, 2018, Oncology Letters CrossRef
17. Matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 and -2 in sera and urine of patients with renal carcinoma
    ANGELINA DI CARLO, 2014, Oncology Letters CrossRef
18. Early detection of kidney cancer using urinary proteins: a truly non‐invasive strategy
    Jordan G. Flitcroft et al, 2022, BJU International CrossRef
19. Epigenetic silencing of DACH1 induces the invasion and metastasis of gastric cancer by activating TGF‐β signalling
    Wenji Yan et al, 2014, Journal of Cellular and Molecular Medicine CrossRef
20. Matrix metalloproteinases in Vietnamese patients with colorectal cancer
    Thao Phuong Bui et al, 2017, Oncology Letters CrossRef
21. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer
    Wenji Yan et al, 2018, Clinical Epigenetics CrossRef
22. Biomarkers in Urological Cancers
    Bulent Onal et al, 2022, Biomarkers in Medicine CrossRef
23. Molecular Biomarkers and Treatments for Renal Cell Carcinoma
    Juan Chipollini et al, 2015, Biomarkers in Kidney Disease CrossRef
24. Combination of Anti-Angiogenics and Immunotherapies in Renal Cell Carcinoma Show Their Limits: Targeting Fibrosis to Break through the Glass Ceiling?
    Manon Teisseire et al, 2024, Biomedicines CrossRef